Pancreatic Cancer Research

ResearcherYamagata UniversityNo recent work listed

Shuhei Suzuki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-8108-3230; OpenAlex author ID A5024433211. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: 2 papers · 2020: 2 papers

Papers 6

  1. FOLFIRINOX as second-line chemotherapy for advanced pancreatic cancer: A subset analysis of data from a nationwide multicenter observational study in Japan. Co-author DOI 10.1016/j.pan.2020.07.006↗
  2. Therapeutic targeting of pancreatic cancer stem cells by dexamethasone modulation of the MKP-1-JNK axis. Co-author DOI 10.1074/jbc.ra120.015223↗
  3. FOLFIRINOX for locally advanced pancreatic cancer: Results and prognostic factors of subset analysis from a nation-wide multicenter observational study in Japa… Co-author DOI 10.1016/j.pan.2019.01.001↗
  4. Brexpiprazole Reduces Survivin and Reverses EGFR Tyrosine Kinase Inhibitor Resistance in Lung and Pancreatic Cancer. First author DOI 10.21873/anticanres.13667↗
  5. Rho-Associated Protein Kinase (ROCK) Inhibitors Inhibit Survivin Expression and Sensitize Pancreatic Cancer Stem Cells to Gemcitabine. Co-author DOI 10.21873/anticanres.11227↗
  6. JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cells. Co-author DOI 10.18632/oncotarget.2693↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chifumi Kitanaka · 4 shared papers, 2015–2020 · strength 0.33
  2. Tomomi Sanomachi · 3 shared papers, 2016–2020 · strength 0.28
  3. Masahiro Yamamoto · 2 shared papers, 2019–2020 · strength 0.22
  4. Takashi Yoshioka · 3 shared papers, 2015–2019 · strength 0.21
  5. Akira Fukutomi · 2 shared papers, 2019–2020 · strength 0.17
  6. Keiko Kamei · 2 shared papers, 2019–2020 · strength 0.17
  7. Nobumasa Mizuno · 2 shared papers, 2019–2020 · strength 0.17
  8. Satoshi Kobayashi · 2 shared papers, 2019–2020 · strength 0.17
  9. Masato Ozaka · 2 shared papers, 2019–2020 · strength 0.17
  10. Akiko Todaka · 2 shared papers, 2019–2020 · strength 0.17
  11. Hideki Ueno · 2 shared papers, 2019–2020 · strength 0.17
  12. Atsushi Satō · 2 shared papers, 2015–2020 · strength 0.17
  13. Hiroyuki Takeda · 2 shared papers, 2015–2016 · strength 0.11
  14. Kentaro Sudo · 1 shared paper, 2020 · strength 0.09
  15. Atsushi Yamaguchi · 1 shared paper, 2020 · strength 0.09
  16. Naohiro Okano · 1 shared paper, 2020 · strength 0.09
  17. Hideyuki Hayashi · 1 shared paper, 2020 · strength 0.09
  18. Noritoshi Kobayashi · 1 shared paper, 2020 · strength 0.09
  19. Ippei Matsumoto · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.